Pomalidomide, bortezomib, and dexamethasone vs bortezomib and dexamethasone in relapsed or refractory multiple myeloma (OPTIMISMM): final survival outcomes from a randomized, open-label, phase 3 trial


BEKSAÇ M., Richardson P., Oriol A., Lindsay J., Schjesvold F., Galli M., ...More

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Publication Date: 2023
  • Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Ankara University Affiliated: Yes